tiprankstipranks
ABIONYX Pharma SA (FR:ABNX)
:ABNX
France Market
ABNX
ABIONYX Pharma SA
RESEARCH TOOLSreports

ABIONYX Pharma SA (ABNX) Income Statement

5 Followers

ABIONYX Pharma SA Income Statement

Last quarter (Q4 2025), ABIONYX Pharma SA's total revenue was €1.94M, a decrease of -22.61% from the same quarter last year. In Q4, ABIONYX Pharma SA's net income was €-3.24M. See ABIONYX Pharma SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 4.06M€ 4.60M€ 4.64M€ 5.25M€ 675.00K
Gross Profit
€ 376.00K€ 844.00K€ 618.00K€ 636.00K€ 259.00K
Operating Expenses
€ 6.63M€ 5.31M€ 4.03M€ 4.75M€ 6.21M
Depreciation and Amortization
€ 551.00K€ 478.00K€ -160.00K€ 135.00K€ 119.00K
EBITDA
€ -5.70M€ -4.93M€ -4.84M€ -4.01M€ -7.42M
Operating Income
€ -6.25M€ -5.57M€ -3.41M€ -4.11M€ -5.95M
Other Income/Expenses
€ 17.00K€ 84.00K€ -106.00K€ -97.00K€ 130.00K
Pretax Income
€ -6.24M€ -5.47M€ -3.52M€ -4.21M€ -5.82M
Net Income
€ -5.55M€ -4.40M€ -3.52M€ -4.21M€ -5.82M
Per Share Metrics
Basic EPS
€ -0.15€ -0.13€ -0.12€ -0.15€ -0.23
Diluted EPS
€ -0.15€ -0.13€ -0.12€ -0.15€ -0.23
Weighted Average Shares Outstanding
 35.51M 33.70M 29.35M 27.97M 24.88M
Weighted Average Shares Outstanding (Diluted)
 35.51M 33.70M 29.35M 27.97M 24.88M
Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History